Deaths from tuberculosis: differences between tuberculosis-related and non-tuberculosis-related deaths.

cause-specific mortality comorbididites death demographics symptom tuberculosis

Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
2023
Historique:
received: 17 04 2023
accepted: 09 08 2023
medline: 19 9 2023
pubmed: 18 9 2023
entrez: 18 9 2023
Statut: epublish

Résumé

Tuberculosis (TB) is a major cause of ill health and one of the leading causes of death worldwide. The first step in developing strategies to reduce TB mortality is to identify the direct causes of death in patients with TB and the risk factors for each cause. Data on patients with TB systemically collected from the National Surveillance System of South Korea from January 2019 to December 2020 were included in this study. We analyzed the clinical characteristics associated with TB and non-TB-related deaths, including TB-related symptoms, comorbidities, and radiographic and microbiological findings. Of the total of 12,340 patients with TB, 61% were males with a mean age of 61.3 years. During the follow-up period, the overall mortality rate was 10.6%, with TB-related deaths accounting for 21.3% of all TB deaths. The median survival time in the TB-related death group was 22 days. TB-related death was associated with older age, lower body mass index (BMI), dyspnea, fever, general weakness, bilateral radiographic patterns, and acid-fast bacilli (AFB)-positive smears. Non-TB-related deaths were associated with older age, male sex, lower BMI, comorbidities of heart, liver, kidney, and central nervous system (CNS) diseases, CNS TB involvement, the presence of dyspnea, general weakness, and bilateral radiographic patterns. Patients with high-risk TB must be identified through cause-specific mortality analysis, and the mortality rate must be reduced through intensive monitoring of patients with a high TB burden and comorbidities.

Identifiants

pubmed: 37719730
doi: 10.3389/fpubh.2023.1207284
pmc: PMC10502314
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1207284

Informations de copyright

Copyright © 2023 Jeong, Park, Kim, Min, Ko, Oh, Lee, Yang, Lee, Kim, Chang, Jegal, Lee, Kim and Koo.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Int J Tuberc Lung Dis. 2013 Jan;17(1):54-60
pubmed: 23232005
Tuberc Respir Dis (Seoul). 2020 Jul;83(3):218-227
pubmed: 32610836
Int J Tuberc Lung Dis. 2006 Aug;10(8):857-63
pubmed: 16898369
Eur Respir J. 1998 Apr;11(4):816-20
pubmed: 9623682
Int J Tuberc Lung Dis. 2006 May;10(5):542-9
pubmed: 16704037
PLoS One. 2014 Mar 18;9(3):e92077
pubmed: 24642794
Int J Tuberc Lung Dis. 2006 Nov;10(11):1224-30
pubmed: 17131780
Thorax. 2018 Jan;73(1):70-77
pubmed: 28778918
Clin Microbiol Infect. 2019 Jun;25(6):761.e1-761.e7
pubmed: 30394362
Int J Tuberc Lung Dis. 2008 Mar;12(3):314-8
pubmed: 18284838
Int J Tuberc Lung Dis. 2001 Feb;5(2):113-22
pubmed: 11258504
BMC Infect Dis. 2014 Jan 03;14:5
pubmed: 24387757
Int J Tuberc Lung Dis. 2009 Mar;13(3):328-34
pubmed: 19275792
BMC Infect Dis. 2009 Jun 17;9:95
pubmed: 19531267
Chest. 2004 Oct;126(4):1079-86
pubmed: 15486367
Int J Tuberc Lung Dis. 2011 Jul;15(7):871-85
pubmed: 21496360
Int J Tuberc Lung Dis. 2007 Feb;11(2):143-9
pubmed: 17263283
Clin Infect Dis. 2002 Mar 15;34(6):752-9
pubmed: 11850859
Int J Tuberc Lung Dis. 2003 Aug;7(8):742-50
pubmed: 12921150
Intensive Care Med. 2001 Mar;27(3):513-20
pubmed: 11355119
PLoS One. 2020 Oct 8;15(10):e0240090
pubmed: 33031403
BMC Infect Dis. 2019 Aug 22;19(1):735
pubmed: 31438876
Eur Respir J. 2008 Jun;31(6):1256-60
pubmed: 18515556

Auteurs

Yun-Jeong Jeong (YJ)

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Dongguk University Ilsan Hospital, Goyang, Republic of Korea.

Jae Seuk Park (JS)

Division of Pulmonary Medicine, Department of Internal Medicine, Dankook University College of Medicine, Cheonan, Republic of Korea.

Hyung Woo Kim (HW)

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

Jinsoo Min (J)

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

Yousang Ko (Y)

Division of Pulmonary, Allergy and Critical Care Medicine, Department of Internal Medicine, Kangdong Sacred Heart Hospital, Hallym University College of Medicine, Seoul, Republic of Korea.

Jee Youn Oh (JY)

Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea.

Eun Hye Lee (EH)

Division of Pulmonology, Allergy and Critical Care Medicine, Department of Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.

Bumhee Yang (B)

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju, Republic of Korea.

Min Ki Lee (MK)

Department of Internal Medicine, Pusan National University Hospital, Pusan National University School of Medicine, Busan, Republic of Korea.

Yun Seong Kim (YS)

Department of Internal Medicine, School of Medicine, Pusan National University Yangsan Hospital, Pusan National University and Research Institute of Convergence Biomedical Science and Technology, Busan, Republic of Korea.

Jung Hyun Chang (JH)

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Mokdong Hospital, Ewha Women's University, Seoul, Republic of Korea.

Yangjin Jegal (Y)

Division of Pulmonology, Department of Internal Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan, Republic of Korea.

Sung Soon Lee (SS)

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Republic of Korea.

Ju Sang Kim (JS)

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

Hyeon-Kyoung Koo (HK)

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Republic of Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH